CIK 0001175151
- Non-accelerated filer
- Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980373793
- Phone
- +1 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 4,600 shares at $5.40 ($24,840)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $4.83 ($4,829)
- 4 Open-market buy President and CEO bought 5,000 shares at $4.89 ($24,450)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 77,000 shares (grant or award)
- 4 Open-market buy Director bought 3,000 shares at $4.88 ($14,640)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 68,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 83,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Other acquisition President and CEO acquired 32,539 shares (other)
Page 11 of 20 · 395 filings